The Effect of Left Cardiac Sympathetic Denervation on Exercise in Patients With Long QT Syndrome

Heather N. Anderson, J. Martijn Bos, R. K. Rohatgi, Michael John Ackerman

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objectives: This study evaluated the effect of left cardiac sympathetic denervation (LCSD) on heart rate, cardiac contractility, and cardiopulmonary fitness in human subjects. Background: The primary treatment for long QT syndrome (LQTS) is beta-blocker (BB) therapy, but some patients experience breakthrough cardiac events or intolerable side effects. LCSD provides a significant antifibrillatory, protective effect in LQTS. However, the effect of LCSD on cardiopulmonary fitness in humans has not been previously described. Methods: A retrospective analysis of patients with LQTS and LCSD (2006 to 2017) who had both pre- and post-LCSD exercise stress tests (N = 55; 39 females; mean age at LCSD 22 ± 12 years; mean follow-up 5.1 ± 2.5 years; 36 patients with LQT1; 15 patients with LQT2). Forty patients (73%) were receiving BBs pre-LCSD. Results: Mean peak heart rate before LCSD was 143 ± 23 beats/min, mean peak oxygen consumption (VO2) was 32 ± 10 ml/kg/min, and mean peak respiratory exchange ratio was 1.14 ± 0.12. There was no difference in peak heart rate, peak VO2, peak QTc, or respiratory exchange ratio pre- and post-LCSD. To evaluate the isolated effect of LCSD, the study performed a subset analysis of patients with LCSD monotherapy (n = 10) or no change in BB dose (n = 12). Patient-matched pre- and post-LCSD exercise testing showed no difference in heart rate, VO2, or left ventricular function following LCSD. Conclusions: LCSD provides increased protection from an LQTS-triggered event without negatively affecting peak heart rate, cardiopulmonary fitness, or cardiac contractility, as assessed by both treadmill exercise stress testing and echocardiography.

Original languageEnglish (US)
Pages (from-to)1084-1090
Number of pages7
JournalJACC: Clinical Electrophysiology
Volume5
Issue number9
DOIs
StatePublished - Sep 1 2019

Fingerprint

Long QT Syndrome
Sympathectomy
Exercise
Heart Rate
Exercise Test
Stress Echocardiography
Left Ventricular Function
Oxygen Consumption

Keywords

  • cardiac contractility
  • cardiopulmonary fitness
  • exercise testing
  • left cardiac sympathetic denervation
  • long QT syndrome

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

The Effect of Left Cardiac Sympathetic Denervation on Exercise in Patients With Long QT Syndrome. / Anderson, Heather N.; Bos, J. Martijn; Rohatgi, R. K.; Ackerman, Michael John.

In: JACC: Clinical Electrophysiology, Vol. 5, No. 9, 01.09.2019, p. 1084-1090.

Research output: Contribution to journalArticle

Anderson, Heather N. ; Bos, J. Martijn ; Rohatgi, R. K. ; Ackerman, Michael John. / The Effect of Left Cardiac Sympathetic Denervation on Exercise in Patients With Long QT Syndrome. In: JACC: Clinical Electrophysiology. 2019 ; Vol. 5, No. 9. pp. 1084-1090.
@article{3582041e950d41d7ae09a1ebdc98fdc4,
title = "The Effect of Left Cardiac Sympathetic Denervation on Exercise in Patients With Long QT Syndrome",
abstract = "Objectives: This study evaluated the effect of left cardiac sympathetic denervation (LCSD) on heart rate, cardiac contractility, and cardiopulmonary fitness in human subjects. Background: The primary treatment for long QT syndrome (LQTS) is beta-blocker (BB) therapy, but some patients experience breakthrough cardiac events or intolerable side effects. LCSD provides a significant antifibrillatory, protective effect in LQTS. However, the effect of LCSD on cardiopulmonary fitness in humans has not been previously described. Methods: A retrospective analysis of patients with LQTS and LCSD (2006 to 2017) who had both pre- and post-LCSD exercise stress tests (N = 55; 39 females; mean age at LCSD 22 ± 12 years; mean follow-up 5.1 ± 2.5 years; 36 patients with LQT1; 15 patients with LQT2). Forty patients (73{\%}) were receiving BBs pre-LCSD. Results: Mean peak heart rate before LCSD was 143 ± 23 beats/min, mean peak oxygen consumption (VO2) was 32 ± 10 ml/kg/min, and mean peak respiratory exchange ratio was 1.14 ± 0.12. There was no difference in peak heart rate, peak VO2, peak QTc, or respiratory exchange ratio pre- and post-LCSD. To evaluate the isolated effect of LCSD, the study performed a subset analysis of patients with LCSD monotherapy (n = 10) or no change in BB dose (n = 12). Patient-matched pre- and post-LCSD exercise testing showed no difference in heart rate, VO2, or left ventricular function following LCSD. Conclusions: LCSD provides increased protection from an LQTS-triggered event without negatively affecting peak heart rate, cardiopulmonary fitness, or cardiac contractility, as assessed by both treadmill exercise stress testing and echocardiography.",
keywords = "cardiac contractility, cardiopulmonary fitness, exercise testing, left cardiac sympathetic denervation, long QT syndrome",
author = "Anderson, {Heather N.} and Bos, {J. Martijn} and Rohatgi, {R. K.} and Ackerman, {Michael John}",
year = "2019",
month = "9",
day = "1",
doi = "10.1016/j.jacep.2019.06.008",
language = "English (US)",
volume = "5",
pages = "1084--1090",
journal = "JACC: Clinical Electrophysiology",
issn = "2405-5018",
publisher = "Elsevier USA",
number = "9",

}

TY - JOUR

T1 - The Effect of Left Cardiac Sympathetic Denervation on Exercise in Patients With Long QT Syndrome

AU - Anderson, Heather N.

AU - Bos, J. Martijn

AU - Rohatgi, R. K.

AU - Ackerman, Michael John

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Objectives: This study evaluated the effect of left cardiac sympathetic denervation (LCSD) on heart rate, cardiac contractility, and cardiopulmonary fitness in human subjects. Background: The primary treatment for long QT syndrome (LQTS) is beta-blocker (BB) therapy, but some patients experience breakthrough cardiac events or intolerable side effects. LCSD provides a significant antifibrillatory, protective effect in LQTS. However, the effect of LCSD on cardiopulmonary fitness in humans has not been previously described. Methods: A retrospective analysis of patients with LQTS and LCSD (2006 to 2017) who had both pre- and post-LCSD exercise stress tests (N = 55; 39 females; mean age at LCSD 22 ± 12 years; mean follow-up 5.1 ± 2.5 years; 36 patients with LQT1; 15 patients with LQT2). Forty patients (73%) were receiving BBs pre-LCSD. Results: Mean peak heart rate before LCSD was 143 ± 23 beats/min, mean peak oxygen consumption (VO2) was 32 ± 10 ml/kg/min, and mean peak respiratory exchange ratio was 1.14 ± 0.12. There was no difference in peak heart rate, peak VO2, peak QTc, or respiratory exchange ratio pre- and post-LCSD. To evaluate the isolated effect of LCSD, the study performed a subset analysis of patients with LCSD monotherapy (n = 10) or no change in BB dose (n = 12). Patient-matched pre- and post-LCSD exercise testing showed no difference in heart rate, VO2, or left ventricular function following LCSD. Conclusions: LCSD provides increased protection from an LQTS-triggered event without negatively affecting peak heart rate, cardiopulmonary fitness, or cardiac contractility, as assessed by both treadmill exercise stress testing and echocardiography.

AB - Objectives: This study evaluated the effect of left cardiac sympathetic denervation (LCSD) on heart rate, cardiac contractility, and cardiopulmonary fitness in human subjects. Background: The primary treatment for long QT syndrome (LQTS) is beta-blocker (BB) therapy, but some patients experience breakthrough cardiac events or intolerable side effects. LCSD provides a significant antifibrillatory, protective effect in LQTS. However, the effect of LCSD on cardiopulmonary fitness in humans has not been previously described. Methods: A retrospective analysis of patients with LQTS and LCSD (2006 to 2017) who had both pre- and post-LCSD exercise stress tests (N = 55; 39 females; mean age at LCSD 22 ± 12 years; mean follow-up 5.1 ± 2.5 years; 36 patients with LQT1; 15 patients with LQT2). Forty patients (73%) were receiving BBs pre-LCSD. Results: Mean peak heart rate before LCSD was 143 ± 23 beats/min, mean peak oxygen consumption (VO2) was 32 ± 10 ml/kg/min, and mean peak respiratory exchange ratio was 1.14 ± 0.12. There was no difference in peak heart rate, peak VO2, peak QTc, or respiratory exchange ratio pre- and post-LCSD. To evaluate the isolated effect of LCSD, the study performed a subset analysis of patients with LCSD monotherapy (n = 10) or no change in BB dose (n = 12). Patient-matched pre- and post-LCSD exercise testing showed no difference in heart rate, VO2, or left ventricular function following LCSD. Conclusions: LCSD provides increased protection from an LQTS-triggered event without negatively affecting peak heart rate, cardiopulmonary fitness, or cardiac contractility, as assessed by both treadmill exercise stress testing and echocardiography.

KW - cardiac contractility

KW - cardiopulmonary fitness

KW - exercise testing

KW - left cardiac sympathetic denervation

KW - long QT syndrome

UR - http://www.scopus.com/inward/record.url?scp=85071876158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071876158&partnerID=8YFLogxK

U2 - 10.1016/j.jacep.2019.06.008

DO - 10.1016/j.jacep.2019.06.008

M3 - Article

C2 - 31537339

AN - SCOPUS:85071876158

VL - 5

SP - 1084

EP - 1090

JO - JACC: Clinical Electrophysiology

JF - JACC: Clinical Electrophysiology

SN - 2405-5018

IS - 9

ER -